Tristetraprolin: a weapon against HPV-induced cervical cancer?
作者信息
Gallouzi Imed-Eddine, Di Marco Sergio
机构信息
McGill University, Department of Biochemistry, Rosalind and Morris Goodman Cancer Center, Montreal, Quebec, Canada.
出版信息
Aging (Albany NY). 2009 Oct 8;1(10):839-41. doi: 10.18632/aging.100093.
Abstract
摘要
相似文献
1
Tristetraprolin: a weapon against HPV-induced cervical cancer?Tristetraprolin：对抗人乳头瘤病毒引发的宫颈癌的武器？
Aging (Albany NY). 2009 Oct 8;1(10):839-41. doi: 10.18632/aging.100093.
2
The mRNA decay factor tristetraprolin (TTP) induces senescence in human papillomavirus-transformed cervical cancer cells by targeting E6-AP ubiquitin ligase.信使核糖核酸衰变因子锌指蛋白36（TTP）通过靶向E6相关蛋白泛素连接酶，诱导人乳头瘤病毒转化的宫颈癌细胞衰老。
Aging (Albany NY). 2009 Sep 10;1(9):803-17. doi: 10.18632/aging.100086.
3
Tristetraprolin and E6-AP: Killing the messenger in cervical cancer.锌指蛋白36和E6相关蛋白：宫颈癌中的信使杀手
Cell Cycle. 2010 Aug 15;9(16):3135-6. doi: 10.4161/cc.9.16.12951.
4
Juglone Inhibits Proliferation of HPV-Positive Cervical Cancer Cells Specifically.胡桃醌特异性抑制人乳头瘤病毒阳性宫颈癌细胞的增殖。
Biol Pharm Bull. 2019 Mar 1;42(3):475-480. doi: 10.1248/bpb.b18-00845. Epub 2018 Dec 28.
5
In vitro and in vivo growth inhibition of human cervical cancer cells via human papillomavirus E6/E7 mRNAs' cleavage by CRISPR/Cas13a system.通过 CRISPR/Cas13a 系统切割人乳头瘤病毒 E6/E7 mRNA 抑制人宫颈癌细胞的体外和体内生长。
Antiviral Res. 2020 Jun;178:104794. doi: 10.1016/j.antiviral.2020.104794. Epub 2020 Apr 14.
6
[Mechanisms of high-risk human papillomavirus-induced cervical carcinogenesis].[高危型人乳头瘤病毒诱导宫颈癌发生的机制]
Nihon Rinsho. 2009 Jan;67(1):53-61.
7
Endogenous human papillomavirus E6 and E7 proteins differentially regulate proliferation, senescence, and apoptosis in HeLa cervical carcinoma cells.内源性人乳头瘤病毒E6和E7蛋白对HeLa宫颈癌细胞的增殖、衰老和凋亡有不同的调节作用。
J Virol. 2003 Jan;77(2):1551-63. doi: 10.1128/jvi.77.2.1551-1563.2003.
8
Pembrolizumab plus GX-188E therapeutic DNA vaccine in patients with HPV-16-positive or HPV-18-positive advanced cervical cancer: interim results of a single-arm, phase 2 trial.帕博利珠单抗联合 GX-188E 治疗性 DNA 疫苗治疗 HPV-16 阳性或 HPV-18 阳性晚期宫颈癌患者：一项单臂、2 期临床试验的中期结果。
Lancet Oncol. 2020 Dec;21(12):1653-1660. doi: 10.1016/S1470-2045(20)30486-1.
9
ALA-PDT promotes HPV-positive cervical cancer cells apoptosis and DCs maturation via miR-34a regulated HMGB1 exosomes secretion.ALA-PDT 通过 miR-34a 调控的 HMGB1 外泌体分泌促进 HPV 阳性宫颈癌细胞凋亡和 DCs 成熟。
Photodiagnosis Photodyn Ther. 2018 Dec;24:27-35. doi: 10.1016/j.pdpdt.2018.08.006. Epub 2018 Aug 15.
10
Arsenic trioxide inhibits cell proliferation and human papillomavirus oncogene expression in cervical cancer cells.三氧化二砷抑制宫颈癌细胞的增殖和人乳头瘤病毒癌基因的表达。
Biochem Biophys Res Commun. 2014 Sep 5;451(4):556-61. doi: 10.1016/j.bbrc.2014.08.014. Epub 2014 Aug 10.
引用本文的文献
1
The long non-coding RNA PTTG3P promotes growth and metastasis of cervical cancer through PTTG1.长链非编码RNA PTTG3P通过PTTG1促进宫颈癌的生长和转移。
Aging (Albany NY). 2019 Mar 10;11(5):1333-1341. doi: 10.18632/aging.101830.
本文引用的文献
1
The mRNA decay factor tristetraprolin (TTP) induces senescence in human papillomavirus-transformed cervical cancer cells by targeting E6-AP ubiquitin ligase.信使核糖核酸衰变因子锌指蛋白36（TTP）通过靶向E6相关蛋白泛素连接酶，诱导人乳头瘤病毒转化的宫颈癌细胞衰老。
Aging (Albany NY). 2009 Sep 10;1(9):803-17. doi: 10.18632/aging.100086.
2
Could stress granules be involved in age-related diseases?应激颗粒是否与年龄相关疾病有关？
Aging (Albany NY). 2009 Sep 21;1(9):753-7. doi: 10.18632/aging.100090.
3
Tissue- and age-dependent expression of RNA-binding proteins that influence mRNA turnover and translation.影响mRNA周转和翻译的RNA结合蛋白的组织和年龄依赖性表达。
Aging (Albany NY). 2009 Jul 26;1(8):681-98. doi: 10.18632/aging.100073.
4
Human papillomavirus and the HPV vaccine: are the benefits worth the risks?人乳头瘤病毒与HPV疫苗：益处是否值得冒风险？
Nurs Clin North Am. 2009 Sep;44(3):293-9. doi: 10.1016/j.cnur.2009.06.005.
5
The mRNA-destabilizing protein tristetraprolin is suppressed in many cancers, altering tumorigenic phenotypes and patient prognosis.信使核糖核酸（mRNA）不稳定蛋白锌指蛋白36（Tristetraprolin）在许多癌症中受到抑制，从而改变致瘤表型和患者预后。
Cancer Res. 2009 Jun 15;69(12):5168-76. doi: 10.1158/0008-5472.CAN-08-4238. Epub 2009 Jun 2.
6
Concatenated multitype L2 fusion proteins as candidate prophylactic pan-human papillomavirus vaccines.串联多类型L2融合蛋白作为候选预防性全人乳头瘤病毒疫苗
J Natl Cancer Inst. 2009 Jun 3;101(11):782-92. doi: 10.1093/jnci/djp106. Epub 2009 May 26.
7
Developing vaccines against minor capsid antigen L2 to prevent papillomavirus infection.研发针对次要衣壳抗原L2的疫苗以预防乳头瘤病毒感染。
Immunol Cell Biol. 2009 May-Jun;87(4):287-99. doi: 10.1038/icb.2009.13.
8
Molecular mechanisms of cervical carcinogenesis by high-risk human papillomaviruses: novel functions of E6 and E7 oncoproteins.高危型人乳头瘤病毒致宫颈癌的分子机制：E6和E7癌蛋白的新功能
Rev Med Virol. 2009 Mar;19(2):97-113. doi: 10.1002/rmv.605.
9
Vaccination with HPV16 L2E6E7 fusion protein in GPI-0100 adjuvant elicits protective humoral and cell-mediated immunity.使用GPI-0100佐剂的HPV16 L2E6E7融合蛋白疫苗接种可引发保护性体液免疫和细胞介导免疫。
Vaccine. 2009 Feb 11;27(7):1040-9. doi: 10.1016/j.vaccine.2008.11.099. Epub 2008 Dec 16.
10
Cellular and molecular biological aspects of cervical intraepithelial neoplasia.
Int Rev Cell Mol Biol. 2008;271:35-95. doi: 10.1016/S1937-6448(08)01202-1.
Zotero 插件